...are really big on the upside.” On March 4, Ascendis Pharma A/S reported that its TransCon Growth Hormone...

...A/S, which announced data on March 4 from the Phase III heiGHt trial showing weekly TransCon growth hormone...

...market close. The company lost $10.70 to $114.70 on Wednesday. Ascendis reported Monday that its TransCon Growth Hormone...

...Ascendis gained $51.29 (74%) to $120.60 on Monday after reporting that its TransCon Growth Hormone met the primary...
...Stanley, Credit Suisse, Evercore, Wells Fargo, Cantor Fitzgerald, Canaccord Genuity and Wedbush. Chris Lieu, Staff Writer TransCon Growth Hormone (ACP-001) Ascendis...

...end-stage renal disease patients on hemodialysis Phase III data 2019 Ascendis Pharma A/S (NASDAQ:ASND) TransCon Growth Hormone (ACP-001...

...hours to raise $150 million. The company is conducting a Phase III trial of TransCon Growth Hormone (ACP-001...
...completed in October (see BioCentury, Sept. 29, 2017 ). Ascendis Pharma A/S (NASDAQ:ASND), Hellerup, Denmark Paul Bonanos TransCon Growth Hormone Ascendis...

...$1.43 to $59.43 on Thursday. The company is conducting a Phase III trial of TransCon Growth Hormone (ACP-001...
...the primary endpoint in the Phase III PALISADE trial (see BioCentury Extra, Feb. 20) . Paul Bonanos AR101 TransCon Growth Hormone Aimmune...

...quarter, Ascendis expects to complete enrollment in the Phase III heiGHt trial evaluating its TransCon Growth Hormone (ACP-001...
...manufacturing, and packaging. Ascendis Pharma A/S (NASDAQ:ASND), Hellerup, Denmark Catalent Inc. (NYSE:CTLT), Somerset, N.J. Elizabeth S. Eaton Somavaratan TransCon Growth Hormone Ascendis...

...quarter, Ascendis expects to complete enrollment in the Phase III heiGHt trial evaluating its TransCon Growth Hormone (ACP-001...
...Ascendis was down $2.46 to $34.64 on Wednesday, and Catalent gained $1.06 to $40.27. Elizabeth S. Eaton TransCon Growth Hormone Ascendis...

...its TransCon Growth Hormone (ACP-001) to treat pre-pubertal GHD. Ascendis was off $1.55 to $27.74 on Thursday. Brian Moy ACP-001 Somavaratan TransCon Growth Hormone VRS-317 Amunix...